Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Stryker Community
NYSE:SYK Community
2
Narratives
written by author
0
Comments
on narratives written by author
66
Fair Values set
on narratives written by author
Create a narrative
Stryker
Popular
Undervalued
Overvalued
Community Investing Ideas
Stryker
TO
Tokyo
Community Contributor
Investing in Stryker (SYK) should be an easy ride
Investing in Stryker (SYK) should be an easy ride Key “Take aways”: - Solid balance sheet - Earnings recovered, with positive outlook. - SYK is fair priced.
View narrative
US$323.52
FV
19.4% overvalued
intrinsic discount
6.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
10 months ago
author updated this narrative
Stryker
AN
AnalystConsensusTarget
Consensus Narrative from 28 Analysts
International Expansion And Mako Launches Will Boost Future Position
Key Takeaways Successful international expansion and robotic-assisted surgeries are set to drive significant future revenue growth in targeted segments. Strategic acquisitions and product launches are boosting earnings and expected to maintain or improve net margins amidst economic headwinds.
View narrative
US$424.26
FV
8.9% undervalued
intrinsic discount
8.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
35
users have followed this narrative
Updated
narrative
Your Valuation for
SYK
SYK
Stryker
Your Fair Value
US$
Current Price
US$386.32
38.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
33b
2015
2018
2021
2024
2025
2027
2030
Revenue US$33.3b
Earnings US$4.1b
Advanced
Set Fair Value